The official designation of the HCPCS code G0680 by the Centers for Medicare and Medicaid Services fundamentally alters the financial trajectory of medical artificial intelligence by establishing a dedicated reimbursement pathway for the detection and quantification of coronary artery calcification
The global medical community currently faces a profound paradox where the hazardous byproducts of nuclear energy are becoming the most sought-after ingredients for next-generation oncology treatments. While nuclear waste was historically viewed as a multi-generational liability requiring secure
The clinical landscape for treating aggressive large B-cell lymphoma has undergone a radical transformation with the advent of Chimeric Antigen Receptor T-cell therapy, yet the ability to accurately forecast which patients will achieve long-term remission remains an elusive goal for many oncology
The global medical community currently stands at a transformative crossroads where the successful development of radioligand therapies faces the stark reality of a strained and aging production infrastructure. As of 2026, the Third International Workshop on Medical Radioisotope Supply has
The rapid evolution of Optical Coherence Tomography has transformed it from a niche ophthalmological tool into a versatile powerhouse capable of revealing the microscopic secrets of human tissue across various medical specialties. While clinicians have long relied on this technology to map retinal
Surging oncology and cardiology caseloads have turned nuclear medicine from a niche toolkit into a frontline engine for precise diagnosis and targeted therapy across health systems worldwide, and that shift is showing up in the numbers. The global radiopharmaceuticals market was projected to expand
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34